12:00 AM
 | 
Aug 06, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Almirall, Quintiles sales and marketing update

Almirall and Quintiles partnered to promote Almirall's respiratory products in the U.K. The deal includes aclidinium bromide, which was approved last month in the EU, Iceland and Norway as Bretaris/ Eklira Genuair as maintenance bronchodilator treatment to relieve symptoms in patients with chronic obstructive pulmonary disease (COPD). The drug...

Read the full 228 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >